Abstract: This invention relates to a cement, which comprises in its main phase of microcrystalline magnesium ammonium phosphate and nanoapatite after hardening and thus at the same time has considerable strength. The material is biologically degradable and is suitable for application in tooth cements, as bone replacement, as bone filler, as bone cement or as bone adhesive.
Abstract: A self-foaming bone cement is described herein. In one variation, the bone cements include a self setting calcium phosphate cement formulation which when cured, forms macroscopic pores of varying sizes and densities with sufficient surface area to provide substantial regions for bone turnover.
Type:
Grant
Filed:
June 8, 2006
Date of Patent:
March 24, 2009
Assignees:
Sanatis GmbH, Kyphon SARL
Inventors:
Avram Allan Edidin, Robert Wenz, Jörg Meyer
Abstract: The invention is a silicon substituted oxyapatite compound (Si—OAp) for use as a synthetic bone biomaterial either used alone or in biomaterial compositions. The silicon substituted oxyapatite compound has the formula Ca5(PO4)3-x(SiO4)xO(1-x)/2, where 0<x<1.0.
Type:
Grant
Filed:
March 24, 2005
Date of Patent:
March 3, 2009
Assignee:
Warsaw orthopedic, inc.
Inventors:
Michael Sayer, Joel Reid, Timothy J. N. Smith, Jason Hendry